Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (ETR:MUV2 - Get Free Report)'s share price traded up 1.3% during trading on Wednesday . The company traded as high as €591.40 ($649.89) and last traded at €590.20 ($648.57). 179,461 shares were traded during trading, a decline of 75% from the average session volume of 732,414 shares. The stock had previously closed at €582.40 ($640.00).
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München Price Performance
The company has a market capitalization of $74.55 billion, a PE ratio of 13.01, a P/E/G ratio of 1.50 and a beta of 0.85. The company has a 50-day moving average of €551.07 and a two-hundred day moving average of €511.46.
About Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München
(
Get Free Report)
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München engages in the insurance and reinsurance businesses worldwide. It also offers life and health reinsurance solutions, such as digital underwriting and advanced analytics solutions, health insurance management system, financial market risks, financing, portfolio risk management, digitalized investment-linked solution, MIRA digital suite, MIRA POS, MIRApply insured and physician, claims risk adjustment, CLARA plus, data analytics, underwriting and claims, medical research, capital management, and health market.
Featured Stories
Before you consider Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München wasn't on the list.
While Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
